Webb26 dec. 2024 · AVROBIO, Inc. is a clinical-stage gene therapy biotechnology company focused on developing single-dose curative ex-vivo lentiviral-based gene therapies for rare diseases. WebbSummit Therapeutics Announces Timing of Rights Offering for Up to $500 Million Press Releases / 20 Jan 2024 Summit Therapeutics Closes Deal with Akeso Inc. to In-License …
United States Court of Appeals for the Federal Circuit
Webb13 apr. 2024 · Aldeyra Therapeutics Inc. (NASDAQ:ALDX) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -4.04% to the previous day’s close as strong demand from buyers drove the stock to $9.97. Actively observing the price movement in the last trading, the stock closed the session at $10.39, falling within a … Webb24 jan. 2024 · TScan Therapeutics secured clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug Application to assess TSC-100 in treating patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation (HCT). triborg variations
Sixfold.
Webbför 2 dagar sedan · WESTON, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, announces that Stephen C. … Webb11 apr. 2024 · January 4, 2024. Nurix Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference. SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Nurix … WebbSeismic Therapeutic is addressing the central challenges in biologics discovery and development to realize new medicines to treat diseases of adaptive immunity that have … tere mathe